Linzagolix Demonstrates Nonclinical Safety Across Central Nervous, Cardiovascular, and Respiratory Systems
Non-clinical safety pharmacology assessments showed that linzagolix produced no detectable adverse effects on central nervous, cardiovascular, or respiratory endpoints at ...
